which could lead to treatments for the cognitive symptoms of Parkinson's disease ... New Drug Targets for Alzheimer's Identified from Cerebrospinal Fluid Nov. 14, 2024 — Researchers have linked ...

Now, a breakthrough in the lab may help diagnose both diseases before any signs appear. While medicines like Ozempic or ...

Long-term exposure to antibiotics may significantly raise the risk of Parkinson's disease, finds a study. To validate the ...

Among these new targets, the stimulation ... Subthalamic nucleus stimulation is an effective treatment for motor complications and dyskinesia in Parkinson's disease, but is less effective on ...

Scientists at La Trobe University have created a world-first method to investigate "disordered" proteins in living cells, in ...

Researchers have identified that G-quadruplexes promote harmful protein aggregation in neurodegenerative diseases. Blocking ...

According to the new study, patients with a slow progression ... A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a ...

I’ve described Parkinson’s as an “unforgiving” disease and a “slow crawl into the brambles.” Kathy is the love of my life.

Management of axial signs (postural instability, freezing) and cognitive decline in Parkinson's disease is unsatisfactory with the current medical treatment. Subthalamic nucleus stimulation is an ...

Parkinson’s disease is a brain disorder that affects about one million people in the U.S. It happens when the brain loses ...

Nielsen, Jr., Research Professor of Parkinson's Disease and Movement Disorders, have defined new biologic and clinical biomarkers for better identifying patients with different stages of Parkinson ...

Environmental factors like prolonged stress, chronic inflammation and toxic exposure could play a key role in triggering ...